Abstract

Compounding with Microneedle Arrays, Part 2: Preparation and Administration Methods

Author(s): Allen Loyd V Jr

Issue: Nov/Dec 2022 - Volume 26, Number 6

Page(s): 490-495

Download in electronic PDF format for $75
  • Compounding with Microneedle Arrays, Part 2: Preparation and Administration Methods Page 1
  • Compounding with Microneedle Arrays, Part 2: Preparation and Administration Methods Page 2
  • Compounding with Microneedle Arrays, Part 2: Preparation and Administration Methods Page 3
  • Compounding with Microneedle Arrays, Part 2: Preparation and Administration Methods Page 4
  • Compounding with Microneedle Arrays, Part 2: Preparation and Administration Methods Page 5
  • Compounding with Microneedle Arrays, Part 2: Preparation and Administration Methods Page 6

Abstract

As discussed in the first article in this series, microneedle arrays are minimally invasive devices that can be used to bypass the stratum corneum barrier and thus achieve transdermal drug delivery. Microneedles in various geometries and materials (silicon, metal, polymer) have been produced using microfabrication techniques. Microneedle arrays appear similar to transdermal patches, ranging upwards in size from 1 cm2 to larger sizes depending upon the drug, etc. The concept of microneedle structures to penetrate painlessly the outermost layer of the skin, the stratus corneum, was first introduced in the 1970s. This article, which represents part 2 of this series of articles, discusses the current state of microneedle array development and the compounding opportunities, using the pretreatment approach.

Related Keywords

  • microneedle arrays
  • drug delivery
  • transdermal administration
  • skin penetration
  • stratum corneum
  • percutaneous absorption
  • topical preparations
  • microporation
  • drug diffusion rate
  • hollow bore microneedles
  • solid microneedles
  • microneedle array blanks
  • drug-containing reservoir

Related Categories

  • DERMATOLOGY
  • FORMULATIONS
  • TECHNOLOGY
  • DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jan/Feb 2023
Pg. 30-37
Advanced Compounding: Compounding with Microneedle Arrays, Part 3: Microneedle Array Development in the Literature and Quality Control of Microneedle Arrays
Author(s): Allen Loyd V Jr
Nov/Dec 2022
Pg. 490-495
Compounding with Microneedle Arrays, Part 2: Preparation and Administration Methods
Author(s): Allen Loyd V Jr
Sep/Oct 2022
Pg. 400-408
Basics of Compounding: Compounding with Microneedle Arrays, Part 1: Introduction and Overview
Author(s): Allen Loyd V Jr
Mar/Apr 2003
Pg. 106-113
Veterinary Transdermal Medications: A to Z
Author(s): Davidson Gigi S
Jul/Aug 2011
Pg. 308-315
Transdermals: The Skin as Part of a Drug Delivery System
Author(s): Allen Loyd V Jr
Nov/Dec 2018
Pg. 498-503
Gabapentin in Elastic Liposomes: Preparation, Characterization, Drug Release, and Penetration Through Porcine Skin
Author(s): Le Uyen Minh, Baltzley Sarah, AlGhananeem Abeer
May/Jun 2016
Pg. 250-256
Effect of Penetration Enhancers on the Percutaneous Delivery of Pain Management Actives
Author(s): Trimble John, Light Bob
Jul/Aug 2004
Pg. 269-274
Current Topical Treatments in Wound Healing - Part 1
Author(s): Helmke Christopher D
Mar/Apr 2020
Pg. 168-175
Percutaneous Absorption of Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol from ABH Gel
Author(s): Dahal Amit, Neupane Rabin, Boddu Sai HS, Renukuntla Jwala, Khupse Rahul, Dudley Richard
Sep/Oct 2017
Pg. 356
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Author(s): Allen Loyd V Jr
May/Jun 2014
Pg. 256-261
Preparation and In Vitro Evaluation of a Pluronic Lecithin Organogel Containing Ricinoleic Acid for Transdermal Delivery
Author(s): Boddu Sai HS, Bonam Sindhu Prabha, Wei Yangjie, Alexander Kenneth
Nov/Dec 2014
Pg. 512-515
In Vitro Skin Penetration and Skin Content of Progesterone from Various Topical Formulations
Author(s): Heustess Allie, Asbill Scott, Eagerton David, Arnold John
Nov/Dec 2017
Pg. 530-535
Effect of Penetration Enhancers on the Percuaneous Delivery of Hormone Replacement Actives
Author(s): Trimble John O, Light Bob
May/Jun 2022
Pg. 214-217
Basics of Compounding: Vehicle for Drug Administration via Enteral Feeding Tubes
Author(s): Allen Loyd V Jr
Nov/Dec 2017
Pg. 446-452
Feline Transdermal Formulation Considerations
Author(s): Forsythe Lauren Eichstadt
Jul/Aug 2015
Pg. 303-305
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances
Author(s): Miller David G
Nov/Dec 2015
Pg. 487-488
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs
Author(s): Allen Loyd V Jr
Jul/Aug 2014
Pg. 332-340
Evaluation of Percutaneous Absorption Performance for Human Female Sexual Steroids into Pentravan Cream
Author(s): Polonini Hudson C, Brandão Marcos Antônio F, Ferreira Anderson O, Ramos Cristiano, Raposo Nádia R B
Mar/Apr 2018
Pg. 108-121
Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management
Author(s): Soni Abhishek, Gowthamarajan Kuppusamy, Radhakrishnan Arun
Nov/Dec 2020
Pg. 501-508
Drug-release Assessment of Compounded Topical Nifedipine and Diltiazem in Commonly Used Bases for Wound Healing
Author(s): Teimouri Arezou, Yeung Pollen, Agu Remigius U